Lataa...
Injectable protease-operated depots of glucagon-like peptide-1 provide extended and tunable glucose control
Peptide drugs are an exciting class of pharmaceuticals increasingly used for the treatment of a variety of diseases; however, their main drawback is a short half-life, which dictates multiple and frequent injections and an undesirable “peak-and-valley” pharmacokinetic profile, which can cause undesi...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
National Academy of Sciences
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3581961/ https://ncbi.nlm.nih.gov/pubmed/23359691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1214518110 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|